Precigen (PGEN)

• Market cap: $1.24B
• 1 day: 7.01%
• 5 days: 6.69%
• 1 month: -28.8%
• 3 months: -7.87%
• 6 months: -2.23%
• Year to date: -17.99%
• 1 year: 101.72%
• 5 years: -63.09%
• 10 years: -90.54%
• Sector: Healthcare
• Industry: Biotechnology

About: Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Employees: 25